300601 Shenzhen Kangtai Biological Products

Watchlist

16.08
-0.31-1.89%

Market Closed Jan 3 15:00 CST

17.96BMarket Cap34.88P/E (TTM)

About Shenzhen Kangtai Biological Products Company

The company was founded in 1992, focusing on R&D, production and sales of human vaccines. It has now become one of the leading innovative biopharmaceutical enterprises with strong domestic R&D strength, rich product layout, leading industrial scale, and remarkable progress in internationalization. The company's main business is research and development, production and sales of human vaccines. Major products include recombinant hepatitis B vaccine (10ug, 20ug, 60ug), 23-valent pneumococcal polysaccharide vaccine, acellular haemophilus influenzae type b combination vaccine, 13-valent pneumococcal conjugate vaccine, and freeze-dried human rabies vaccine (human diploid cells). The company has received honors such as Guangdong Innovative Enterprise, Guangdong High-tech Product Certificate, National Torch Program Key High-tech Enterprise Certificate, Guangdong Youth Leading Enterprise, and Shenzhen Science and Technology Progress Award.

Company Profile

Short Name-A康泰生物

Symbol-A300601

Company NameShenzhen Kangtai Biological Products Co.,Ltd.

Listing DateFeb 7, 2017

Issue Price3.29

Shares Offered42.00M share(s)

FoundedSep 8, 1992

Legal Representativeweimin du

General Managerxiang miao

Secretaryjin tao

Accounting FirmShinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)

Securities Representativejin tao

Legal CounselGuo Hao Law Firm (Shenzhen)

Employees609

Phone0755-26988558

Office AddressKangtai Group Building, No. 222 Kefa Road, Science Park Community, Yuehai Street, Nanshan District, Shenzhen

Zip Code518057

Registered Address101 Kangtai Group Building, 222 Kefa Road, Science Park Community, Yuehai Street, Nanshan District, Shenzhen

Fax0755-26988600

Emailoffice@biokangtai.com

Websitehttp://www.biokangtai.com

Business License440301103121741

BusinessDevelopment, production and operation of hepatitis B vaccine and other medical biological products; import and export business (handled in accordance with the qualification certificate); investment in pharmaceutical projects and other industries (specific projects are declared separately); pharmaceutical technology development, information consulting services, own housing, equipment rental services (excluding restricted projects); general freight; special transportation of goods (refrigeration and preservation); non-residential real estate leasing; property management; conference and exhibition services.

Company Executives

Name
Position
Salary

weimin du
Chairman, Directors, Chairman of the Strategy Committee
3.51M

feidong wen
Vice Chairman, Directors, Audit Committee Member
2.11M

jiankai liu
Directors, VP, Nomination Committee Members
3.58M

xiang miao
Directors, President, Strategy Committee Member, Member of the Remuneration and Assessment Committee
3.50M

jiaoyu li
Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
150.00K

zhiquan luo
Independent Directors, Audit Committee Member, Chairman of the Nomination Committee
150.00K

keping hu
Independent Directors, Chairman of the Remuneration and Assessment Committee, Strategy Committee Member, Nomination Committee Members
150.00K

jin tao
Board Secretary, Securities Affairs Representative
1.15M

zhiyun lv
Chairman of the Supervisory Board, Shareholder Supervisors
60.00K

hui zhou
Chief Financial Officer
1.37M

aiping yin
Employee Supervisors
212.90K

qiaoming xiang
Employee Supervisors
--

Heat List

Overall

No Data